PDT Partners’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,847
| Closed | -$601K | – | 683 |
|
|
2025
Q1 | $601K | Sell |
14,847
-122,183
| -89% | -$4.95M | 0.04% | 491 |
|
|
2024
Q4 | $3.81M | Sell |
137,030
-2,266
| -2% | -$63K | 0.34% | 85 |
|
|
2024
Q3 | $4M | Hold |
139,296
| – | – | 0.35% | 58 |
|
|
2024
Q2 | $3.27M | Buy |
139,296
+14,848
| +12% | +$348K | 0.31% | 93 |
|
|
2024
Q1 | $3.14M | Buy |
+124,448
| New | +$3.14M | 0.3% | 104 |
|
|
2022
Q4 | – | Sell |
-24,593
| Closed | -$837K | – | 617 |
|
|
2022
Q3 | $837K | Sell |
24,593
-14,279
| -37% | -$486K | 0.13% | 269 |
|
|
2022
Q2 | $367K | Buy |
+38,872
| New | +$367K | 0.03% | 693 |
|